Molecular Partners AG annual revenue
2019
2020
2021
2022
2023
2024
2025
Molecular Partners AG reported CHF0 in revenue for fiscal 2025, a decrease of 100.00% from the previous fiscal year.
View full Molecular Partners AG company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF0 | −CHF5.0M | −100.00% |
| 2024 | 2024-12-31 | CHF5.0M | −CHF2.1M | −29.38% |
| 2023 | 2023-12-31 | CHF7.0M | −CHF182.6M | −96.29% |
| 2022 | 2022-12-31 | CHF189.6M | CHF179.8M | +1843.82% |
| 2021 | 2021-12-31 | CHF9.8M | CHF410,000 | +4.39% |
| 2020 | 2020-12-31 | CHF9.3M | −CHF11.0M | −54.16% |
| 2019 | 2019-12-31 | CHF20.4M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF0 | CHF0 | — |
| Q1 2026 | 2026-03-31 | CHF0 | CHF0 | — |
| Q4 2025 | 2025-12-31 | CHF0 | — | — |
| Q3 2025 | 2025-09-30 | CHF0 | — | — |
| Q2 2025 | 2025-06-30 | CHF0 | −CHF1.6M | −100.00% |
| Q1 2025 | 2025-03-31 | CHF0 | — | — |
| Q2 2024 | 2024-06-30 | CHF1.6M | CHF1.1M | +273.73% |
| Q2 2023 | 2023-06-30 | CHF415,000 | −CHF11.3M | −96.47% |
| Q2 2022 | 2022-06-30 | CHF11.8M | — | — |
Molecular Partners AG's latest reported quarter, Q2 2026, generated CHF0 in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Molecular Partners AG source filings ↗